Estimates of the severity of coronavirus disease 2019: a model-based analysis

  title={Estimates of the severity of coronavirus disease 2019: a model-based analysis},
  author={Robert Verity and Lucy C. Okell and Ilaria Dorigatti and Peter Winskill and Charles Whittaker and Natsuko Imai and Gina Cuomo-Dannenburg and Hayley A. Thompson and Patrick G. T. Walker and Han Fu and Amy Dighe and Jamie T. Griffin and Marc Baguelin and Sangeeta Bhatia and Adhiratha Boonyasiri and Anne Cori and Zulma M. Cucunub{\'a} and Richard G. FitzJohn and Katy A. M. Gaythorpe and Will Green and Arran Hamlet and Wes Hinsley and Daniel J. Laydon and Gemma L. Nedjati-Gilani and Steven Riley and Sabine L van Elsland and Erik M. Volz and Haowei Wang and Yuanrong Wang and Xiaoyue Xi and Christl Ann Donnelly and Azra C. Ghani and Neil M. Ferguson},
  journal={The Lancet. Infectious Diseases},
  pages={669 - 677}

Figures and Tables from this paper

Case fatality risk of the first pandemic wave of novel coronavirus disease 2019 (COVID-19) in China
  • Xiaowei Deng, Juan Yang, Hongjie Yu
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2020
The CFR estimates based on laboratory-confirmed cases ascertained in mainland China suggest that COVID-19 is more severe than the 2009 H1N1 influenza pandemic in hospitalized patients, particularly in Wuhan.
An empirical estimate of the infection fatality rate of COVID-19 from the first Italian outbreak
Empirical estimates based on population level data show a sharp difference in fatality rates between young and old people and firmly rule out overall fatality ratios below 0.5% in populations with more than 30% over 60 years old.
Assessing the age- and gender-dependence of the severity and case fatality rates of COVID-19 disease in Spain
The procedures used to obtain the CFR estimates require strong assumptions and although the interpretation of their magnitude should be treated with caution, the differences observed by age and gender are fundamental underpinnings to inform decision-making.
Assessing Relative Coronavirus Disease 2019 Mortality: A Swiss Population-based Study
The relative risks presented here help to develop a more comprehensive understanding of the actual impact of covid-19, and were higher for males compared to females, both in the general population and in positively tested persons.
Estimating the Risk of Death from COVID-19 in Adult Cancer Patients
Age-specific mortality and immunity patterns of SARS-CoV-2
The relative risk of COVID-19-associated death for younger individuals (under 65) is consistent across countries and can be used to robustly compare the underlying number of infections in each country, and the age distribution of deaths in younger age groups is very consistent across different settings.
Relative Coronavirus Disease 2019 Mortality: A Swiss Population-based Study
A confirmed SARS-CoV-2 infection substantially increased the probability of death across all patient groups, ranging from nine (6 to 15) times the population mortality in 35-year old infected females to a 53-fold increase for 95 year old infected males.
Basic Reproduction Rate and Case Fatality Rate of COVID-19: Application of Meta-analysis
It is found that one person is likely to infect two to three persons in the absence of any control measures, and around three per cent of the population are at the risk of death within one-and-a-half months from the onset of disease COVID-19 in a generalised population.
Prevalence of severe illness and mortality among coronavirus disease(COVID-19) confirmed patients: A systematic review and meta-analysis.
Infection with COVID-19 is associated with significant severe illness and mortality and everyone should take actions, such as hand washing with sanitizer, social distancing, avoid crowding, to help slow the spread of CO VID-19 and protect older adults from severe illness.
Temporal estimates of case-fatality rate for COVID-19 outbreaks in Canada and the United States
The estimates suggest that, if the reporting rate is less than 50%, the adjusted CFR of COVID-19 in Canada is likely to be less than 2%, and the CFR estimates for the US were higher than those for Canada, but theadjusted CFR still remained below 2%.


Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases
It is argued that the current COVID-19 epidemic has a substantial potential for causing a pandemic and the proposed approach provides insights in early risk assessment using publicly available data.
Clinical Characteristics of Coronavirus Disease 2019 in China
During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness, and patients often presented without fever, and many did not have abnormal radiologic findings.
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
There is evidence that human-to-human transmission has occurred among close contacts since the middle of December 2019 and considerable efforts to reduce transmission will be required to control outbreaks if similar dynamics apply elsewhere.
Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts
This work shows that heightened surveillance and isolation, particularly contact tracing, reduces the time cases are infectious in the community, thereby reducing R.CoV-2's overall impact, however, its overall impact is uncertain and highly dependent on the number of asymptomatic cases.
Methods for Estimating the Case Fatality Ratio for a Novel, Emerging Infectious Disease
The authors propose a novel method for estimating the case fatality ratio based on the Kaplan-Meier survival procedure, jointly considering two outcomes (death and recovery), and evaluate its performance by using data from the 2003 epidemic of severe acute respiratory syndrome in Hong Kong.
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
As of early February 2020, compared with patients initially infected with SARS-Cov-2 in Wuhan, the symptoms of patients in Zhejiang province are relatively mild.
A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan
The large discrepancy in crude fatality ratios across the three regions can only be partly explained by epidemiological and clinical heterogeneities and underline the importance of a common data collection platform in an emerging epidemic.